Response Biomedical Corp. (RPBIF.OB) Enters Into Exclusive Italian Distribution Agreement
Response Biomedical Corp. develops, manufactures and markets rapid on-site diagnostic tests for use with its RAMP platform for clinical and environmental applications. The RAMP system consists of a reader and single-use disposable test cartridges. It has the potential to be adapted to more than 250 medical and non-medical tests and provide highly sensitive and reliable information in mere minutes. RAMP clinical tests are commercially available for the early detection of heart attack and congestive heart failure. In the non-clinical market, RAMP tests are currently provided for the environmental detection of West Nile Virus and biodefense applications including the rapid on-site…